Hengsai Biotechnology
PrivateLast Round
Strategic
Dec 30, 2025
Total Funding Raised
$22.87M
Company Overview
Hengsai Biotechnology is a biotechnology company that develops therapeutic dendritic cell (DC) vaccines for the treatment of tumors, chronic viral infections, and autoimmune diseases.
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Hengsai Biotechnology Comps
Public and private peers based on sector, stage, and business model.
Hengsai Biotechnology Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Strategic | Dec 30, 2025 | ||||
| Series A Extension | Jan 17, 2024 | ||||
| Series A | Nov 27, 2023 | ||||
| Pre Seed | Apr 20, 2022 |
Hengsai Biotechnology Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Fuhui Venture Capital | Series A, Pre Seed |
| Beijing Chengming Private Equity Fund Management Co., Ltd. | Series A Extension |
| Zhongshan Cuiheng Group Co., Ltd. | Series A Extension |
| Tasly Capital | Strategic |
| Zhongshan Venture Capital Co., Ltd. | Series A Extension |
Market signals
Structured signals derived from secondary market and firmographic data.
- Dec 31, 2025
Led by Tasly Capital
- Dec 30, 2025
Led by Tasly Capital
Hengsai Biotechnology Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Hengsai Biotechnology's valuation, stock price, and market status.
